Title
Recognition and screening for Chagas disease in the USA
Date Issued
01 January 2021
Access level
open access
Resource Type
review
Author(s)
Marcus R.
Henao-Martínez A.F.
Nolan M.
Livingston E.
Klotz S.A.
Miranda-Schaeubinger M.
Meymandi S.
Johns Hopkins Bloomberg School of Public Health
Publisher(s)
SAGE Publications Ltd
Abstract
Chagas disease (CD), caused by the protozoan Trypanosoma cruzi, is a public health concern, mainly among countries in South and Central America. However, despite the large number of immigrants from endemic countries living in the USA, awareness of CD is poor in the medical community, and therefore it is significantly underdiagnosed. To avoid the catastrophic cardiac complications of CD and to prevent maternal–fetal transmission, widespread educational programs highlighting the need for diagnosis are urgently needed.
Volume
8
Language
English
OCDE Knowledge area
Enfermedades infecciosas
Parasitología
Subjects
Scopus EID
2-s2.0-85115632207
Source
Therapeutic Advances in Infectious Disease
ISSN of the container
20499361
Sponsor(s)
The initial idea for the manuscript was raised at an advisory board organized by Bayer where CD was discussed. This publication and its content are solely the responsibility of the authors. Editorial assistance was provided by Simpson Healthcare, which was funded by Bayer. Simpson Healthcare is committed to adhering to the prevailing standards for ‘Good Publication Practice’ (GPP3), as well as the criteria for authorship established by the International Committee of Medical Journal Editors.
Sources of information:
Directorio de Producción Científica
Scopus